• SGC-CBP30: Precision CREBBP/EP300 Bromodomain Inhibitor for

  2026-04-30

  SGC-CBP30 empowers researchers to dissect transcriptional coactivator mechanisms in cancer and epigenetics, offering unmatched selectivity for CREBBP/EP300. Discover advanced workflows, troubleshooting strategies, and how novel insights into super-enhancer hijacking in lung adenocarcinoma can transform experimental design.

• Type III Collagen Restricts Breast Tumor Progression and Met

  2026-04-30

  This study demonstrates that type III collagen (Col3) in the breast cancer microenvironment suppresses tumor growth and metastasis, with higher Col3:Col1 ratios linked to improved patient outcomes. The findings highlight Col3 as a potential prognostic marker and therapeutic target in breast cancer management.

• Cyclosporin A in Research: Protocols, Applications, and Pitf

  2026-04-29

  Cyclosporin A enables precise inhibition of T-cell activation, mitochondrial pore regulation, and immunosuppressive modeling in both in vitro and in vivo systems. This guide distills advanced workflows, experimental pitfalls, and troubleshooting strategies for maximizing reproducibility and mechanistic insight using APExBIO’s Cyclosporin. Learn how recent reference studies are reshaping experimental design and interpretation in immunology and mitochondrial research.

• Optimizing Immunoassays with HyperFluor 488 Goat Anti-Human

  2026-04-29

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody delivers exceptional sensitivity and versatility for immunoassays across Western blotting, immunofluorescence, and flow cytometry. Explore data-backed protocols, troubleshooting strategies, and translation of vaccine research insights to maximize your assay reliability.

• MEK1/2-ERK1/2 Pathway Drives Lung Hemorrhage in Murine Lupus

  2026-04-28

  This study demonstrates that activation of the MEK1/2-ERK1/2 signaling pathway mediates lung endothelial injury and altered hemostasis, promoting diffuse alveolar hemorrhage (DAH) in a murine model of lupus. Pharmacological inhibition of MEK1/2 or ERK1/2—particularly with Trametinib (GSK1120212)—prevents DAH, highlighting a defined molecular target for future research into severe pulmonary complications in systemic lupus erythematosus.

• Spermine for Reliable Ion Channel Modulation: Lab Scenarios

  2026-04-28

  This article delivers evidence-based guidance for biomedical researchers navigating the complexities of cell viability and ion channel assays, featuring Spermine (SKU C4910). Readers gain actionable insights into protocol optimization, product selection, and data interpretation—anchored by real laboratory challenges and supported by quantitative data.

• Procainamide Hydrochloride: Applied Workflows in Cardiac and

  2026-04-27

  Procainamide Hydrochloride, a dual-action cardiac sodium channel blocker and DNMT1 inhibitor, is transforming both cardiac electrophysiology and oncology workflows. This article details experimental protocols, liposomal delivery innovations, and troubleshooting guidance, providing actionable insights for bench scientists seeking robust, reproducible results.

• NEXMIF Overexpression Drives ASD-like Behaviors and Synaptic

  2026-04-27

  This study demonstrates that overexpression of the X-linked gene NEXMIF in mice induces autism-like behavioral phenotypes and significant alterations in neuronal structure and gene expression. The findings provide mechanistic insight into how NEXMIF dosage impacts neural circuitry relevant to autism spectrum disorder (ASD) and intellectual disability.

• Hematoxylin and Eosin Staining Kit: Applied Workflows & Trou

  2026-04-26

  The Hematoxylin and Eosin Staining Kit from APExBIO is uniquely engineered for robust tissue morphology visualization across paraffin and frozen sections, empowering researchers to decode cellular integrity under redox stress and ferroptosis. This article translates frontline mechanistic insight—such as the Keap1/Nrf2/GPX4 axis in lung injury—into actionable, optimized staining protocols and troubleshooting guidance.

• Protein A/G Magnetic Co-IP/IP Kit: Streamlined Co-IP for Pro

  2026-04-25

  Leverage the Protein A/G Magnetic Co-IP/IP Kit for rapid, high-fidelity capture of protein complexes—even in challenging lysates. This kit empowers precise co-immunoprecipitation and antibody purification workflows, supporting advanced studies of protein-protein interactions and post-translational regulation.

• IGFBP2-THBS1 Axis in Growth Hormone Therapy for ISS: Mechani

  2026-04-24

  This study elucidates how recombinant human growth hormone (GH) promotes bone growth in idiopathic short stature (ISS) by activating the IGF-1 pathway through an IGFBP2-mediated inhibition of THBS1. The mechanistic findings clarify the molecular basis of GH therapy and suggest new targets for optimizing treatment efficacy in ISS.

• Gemcitabine HCl: Advancing Translational Pancreatic Cancer R

  2026-04-24

  Explore how Gemcitabine HCl, a gold-standard DNA synthesis inhibitor, is reshaping translational research in pancreatic cancer. This article delivers mechanistic clarity, protocol precision, and strategic guidance, synthesizing breakthrough multianimal MRI workflows and evidence from leading KPC mouse model studies. Researchers will gain actionable insights into high-throughput, quantitative tumor suppression assays, optimal compound handling, and integration with next-generation imaging—all grounded in rigorously sourced data and workflow innovation.

• Proteoform-Specific Drug Targeting in Native Cell Signaling

  2026-04-23

  This study pioneers the direct characterization of proteoform-specific interactions within native cell membranes, using advanced mass spectrometry to reveal how post-translational modifications shape protein-ligand binding. The findings refine our understanding of off-target effects for cGMP-specific phosphodiesterase type 5 inhibitors and inform more precise drug development in complex biological systems.

• (S)-(+)-Dimethindene maleate: Technical Guidance for M2 Anta

  2026-04-23

  (S)-(+)-Dimethindene maleate is a selective M2 muscarinic receptor antagonist with concurrent histamine H1 antagonism, offering researchers a tool for dissecting muscarinic acetylcholine signaling in autonomic regulation, cardiovascular, and respiratory studies. It should be employed where high subtype selectivity and solution stability are critical, but is not suitable for diagnostic or therapeutic applications or for experiments requiring in vivo-validated specificity.

• YTHDF1 Phase Separation Drives SSC Transdifferentiation via

  2026-04-22

  Fang et al. (2023) reveal that liquid-liquid phase separation (LLPS) of YTHDF1, an m6A reader protein, is essential for the direct transdifferentiation of spermatogonial stem cells (SSCs) into neural stem cell-like cells. By selectively inhibiting IkBa/b mRNA translation, YTHDF1 LLPS activates the IkB-NF-κB-CCND1 pathway, establishing a new mechanistic paradigm for cell fate transitions with implications for stem cell biology and translational medicine.

15489 records 1/1033 page Next 12345 下5页 Last page